Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Filings indexed 1,608 across all filing types
Latest filing 2020-12-15 Director's Dealing
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
109年11月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, senior management, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares for various insiders. There is no indication of financial statements, earnings data, or report summaries. The content is focused on insider shareholdings and transactions. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is sufficient and contains substantive data, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2020-12-15 Chinese
109年11月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current and pledged shares. It includes specific data on share counts and relationships but does not contain financial statements, earnings data, or narrative management discussion. The document is relatively short (2965 characters) and focuses on insider shareholdings rather than financial results or corporate governance policies. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions or holdings by company directors and executives. There is no indication that this is an announcement of a report or a certification, so it is not RPA or RNS. Therefore, the best classification is DIRS with high confidence.
2020-12-15 Chinese
109年11月營業收入
Interim / Quarterly Report Classification · 90% confidence The document is a revenue summary report from a listed company, showing monthly and cumulative net operating revenue figures with percentage changes and explanations. It is a brief financial data disclosure, typical of periodic revenue updates rather than a full financial report. The document length is short (811 characters), and it does not contain comprehensive financial statements or detailed analysis. It is not an announcement of a report publication but a direct disclosure of financial figures. This fits best with an Interim / Quarterly Report (IR) category, as it provides substantive financial data for a period shorter than a full fiscal year.
2020-12-08 Chinese
109年11月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (中化生) reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It is a short, factual update without detailed financial statements or analysis. The content is typical of a regulatory announcement providing compliance information rather than a full report or detailed financial data. Given the short length (602 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2020-12-08 Chinese
公告本公司董事會決議取得有價證券
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (1762 中化生) regarding a board resolution to acquire securities. It details the transaction date, amount, purpose (strategic investment), and compliance with relevant regulations. The document is short (1098 characters) and primarily serves as a regulatory disclosure of a securities acquisition transaction by the company, not a full financial report or detailed analysis. It does not contain financial statements or comprehensive financial data. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2020-11-27 Chinese
109年11月法人說明會簡報 — 176220201124E001.pdf
Investor Presentation Classification · 95% confidence The document is titled 'Third Quarter 2020 Investor Conference' and includes detailed financial data for the first nine months of 2020, including consolidated income statements, profitability analysis, sales distribution, product growth, and future outlook. It is presented as a detailed presentation with forward-looking statements and business strategy information. The content is typical of an investor presentation focusing on financials, strategy, and market position rather than a formal quarterly report or earnings release. The length (over 11,000 characters) and detailed financial and strategic content support classification as an Investor Presentation rather than a brief earnings release or regulatory filing. There is no indication that this is a transcript, audit report, or annual report. Therefore, the most appropriate classification is Investor Presentation (IP).
2020-11-24 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.